Kolaja Carey OConnor
Insider CIK 1848717 · RVNC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 15,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 16,561 | $3.65 | $60.4K | 15,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2024-05-01 | 2024-05-03 | 23,458 | — | $0 | 23,458 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-05-01 | 2024-05-03 | 15,000 | — | $0 | 31,561 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2023-06-15 | 2023-06-20 | 2,500 | — | $0 | 8,256 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2023-06-15 | 2023-06-20 | 2,500 | $18.12 | $45.3K | 19,061 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-06-15 | 2023-06-20 | 2,500 | $28.24 | $70.6K | 16,561 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-05-03 | 2023-05-05 | 5,915 | — | $0 | 5,915 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-05-03 | 2023-05-05 | 3,534 | — | $0 | 16,561 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-06 | 11,343 | — | $0 | 11,343 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-13 | 10,756 | — | $0 | 10,756 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-05-04 | 2022-05-06 | 6,059 | — | $0 | 13,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-05-05 | 2021-05-07 | 1,268 | — | $0 | 1,268 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-05-05 | 2021-05-07 | 674 | — | $0 | 6,968 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-02 | 11,417 | — | $0 | 11,417 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-03-01 | 2021-03-02 | 6,294 | — | $0 | 6,294 | SEC↗ |